<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05013840</url>
  </required_header>
  <id_info>
    <org_study_id>INCEPTION</org_study_id>
    <nct_id>NCT05013840</nct_id>
  </id_info>
  <brief_title>Opinions of Healthcare Providers About Neuromodulation</brief_title>
  <official_title>Opinions of Healthcare Providers About Neuromodulation for Pain: an Online Survey</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Moens Maarten</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitair Ziekenhuis Brussel</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this online survey is to gain further insight in the goals, expectations and&#xD;
      definition of success for neuromodulation for pain, according to healthcare providers.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 2, 2021</start_date>
  <completion_date type="Anticipated">September 4, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 4, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Physician goals, evaluated with a self-constructed question.</measure>
    <time_frame>Cross-sectional evaluation during 2nd Joint Congress of the INS European Chapters (e-INS 2021) in Paris in September.</time_frame>
    <description>Goals of physicians to treat patients with neuromodulation for pain.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Physician expectations, evaluated with a self-constructed question.</measure>
    <time_frame>Cross-sectional evaluation during 2nd Joint Congress of the INS European Chapters (e-INS 2021) in Paris in September.</time_frame>
    <description>Factors that respondents expect to change according to neuromodulation for pain.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Physician definition of success, evaluated with a self-constructed question.</measure>
    <time_frame>Cross-sectional evaluation during 2nd Joint Congress of the INS European Chapters (e-INS 2021) in Paris in September.</time_frame>
    <description>Physician definition of success of neuromodulation for pain.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Neuromodulation</condition>
  <condition>Pain</condition>
  <condition>Survey</condition>
  <arm_group>
    <arm_group_label>Physicians using neuromodulation</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Filling in an online survey</intervention_name>
    <description>Physicians are asked to fill in an online survey regarding 1) goals to treat patients with neuromodulation for pain, 2) factors that respondents expect to change according to neuromodulation for pain and 3) their definition of success of neuromodulation for pain.</description>
    <arm_group_label>Physicians using neuromodulation</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Male and female adults who are involved in the management of chronic pain and more&#xD;
        specifically in neuromodulation for pain (including but not limited to anesthesiologists,&#xD;
        neurosurgeons, nurses).The survey will be spread at the 2nd Joint Congress of the INS&#xD;
        European Chapters (e-INS 2021) in Paris from 2/9/2021 to 4/9/2021.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        - Male and female adults who are involved in the management of chronic pain and more&#xD;
        specifically in neuromodulation for pain (including but not limited to anesthesiologists,&#xD;
        neurosurgeons, nurses).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        - Not involved in management of chronic pain through neuromodulation.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Vrije Universiteit Brussel</name>
      <address>
        <city>Brussels</city>
        <zip>1090</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maarten Moens, prof. dr.</last_name>
      <phone>+3224775514</phone>
      <email>maarten.moens@uzbrussel.be</email>
    </contact>
    <investigator>
      <last_name>Lisa Goudman</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>William Alliet</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>August 4, 2021</study_first_submitted>
  <study_first_submitted_qc>August 18, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 19, 2021</study_first_posted>
  <last_update_submitted>September 5, 2021</last_update_submitted>
  <last_update_submitted_qc>September 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Universitair Ziekenhuis Brussel</investigator_affiliation>
    <investigator_full_name>Moens Maarten</investigator_full_name>
    <investigator_title>principal investigator</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

